Welcome to the e-CCO Library!

search
Search by: 
Year: Category: Sub Type:
Open surgery for IBD patients: Never?
Year: 2019
Source: 8th S-ECCO IBD Masterclass
Authors: Fabrizio Michelassi
Created: Wednesday, 5 June 2019, 9:01 PM
Opening
Year: 2018
Source: ECCO'18 Vienna
Authors: Panés Julián
Created: Friday, 23 March 2018, 12:23 PM
Opioids, dysbiosis and worsening gut inflammation - a causal link?
Year: 2019
Source: JCC Podcast
Authors: Umakant Sharma et al.
Created: Friday, 28 February 2020, 1:38 PM by Dauren Ramankulov
Last Modified: Tuesday, 13 October 2020, 3:44 PM by Martina Baeva

Umakant Sharma reports his work linking prescription opioids with increased gut dysbiosis, alterations in epithelial tight junction function and colitis severity in 2 different murine models of colitis.

Opportunistic Infections
Year: 2021
Source: Educational Audio Podcasts
Authors: Torsten Kucharzik
Created: Wednesday, 10 March 2021, 1:49 PM by Dauren Ramankulov
Last Modified: Friday, 13 January 2023, 12:14 PM by ECCO Administrator
Optimising reporting in surgery, endocsopy and histopathology
Year: 2022
Source: 11th S-ECCO IBD Masterclass
Authors: Marietta Iacucci
Created: Tuesday, 24 May 2022, 8:13 PM
Summary content

1. To establish a standard terminology for the elaboration of trusted reports in endoscopy, surgery and histopathology
2. To provide i interpretation guidance for dysplasia and cancer, surgical indication and strategies including margins and extent of resection, assessment of disease activity.
3. To standardise the  interpretation of biopsies and specimens.

4.To prove useful these recommendations in daily care of IBD patients

Oral Presentation: Challenges in managing the elderly
Year: 2019
Source: Scientific Programme
Authors: Guillaume Savoye
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP01: In-depth characterization of host-genetics and gut microbiome unravels novel host-microbiome interactions in Inflammatory Bowel Disease
Year: 2019
Source: Scientific Programme
Authors: Shixian Hu
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP02: The role of PTPN2 SNP in the pathogenesis of fibrosis in Crohn’s Disease
Year: 2019
Source: Scientific Programme
Authors: Chao Li
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP07: Analysing intestinal organoids in a multi-omics, systems biology framework to investigate functional processes affected in Crohn’s disease due to autophagy impairment
Year: 2019
Source: Scientific Programme
Authors: Tamas Korcsmaros
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP09: Histological remission and mucosal healing in a randomised, placebo-controlled, phase 2 study of etrasimod in patients with moderately to severely active ulcerative colitis
Year: 2019
Source: Scientific Programme
Authors: Laurent Peyrin-Biroulet
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP10: Systems genomics of ulcerative colitis: combining GWAS and signalling networks for patient stratification and individualised drug targeting in ulcerative colitis
Year: 2019
Source: Scientific Programme
Authors: Johanne Brooks
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP11: Organoids derived from inflamed intestinal biopsies of patients with ulcerative colitis lose their inflammatory phenotype during ex vivo culture
Year: 2019
Source: Scientific Programme
Authors: Kaline Arnauts
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP12: Targeting inflammation in ulcerative colitis by inhibiting glucose uptake
Year: 2019
Source: Scientific Programme
Authors: Roswitha Gropp
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP13: Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and biopsy gene expression analysis: Results from the UNIFI phase 3 induction study
Year: 2019
Source: Scientific Programme
Authors: Katherine Li
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP14: Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately-to-severely active ulcerative colitis: data from the U-ACHIEVE study
Year: 2019
Source: Scientific Programme
Authors: William J. Sandborn
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP16: A randomised, multicentre, double-blind, placebo-controlled study of a targeted release oral cyclosporine formulation in the treatment of mild to moderate ulcerative colitis: efficacy results
Year: 2019
Source: Scientific Programme
Authors: Stuart Bloom
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP17: A molecular measure of inflammation in IBD patients based on transcriptional profiles from 2495 intestinal biopsies
Year: 2019
Source: Scientific Programme
Authors: Mayte Suarez-Farinas
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP18: Proactive adalimumab trough measurements increase corticosteroid-free clinical remission in pediatric patients with Crohn’s disease: The pediatric Crohn's disease adalimumab level-based optimization treatment (PAILOT) trial
Year: 2019
Source: Scientific Programme
Authors: Amit Assa
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP19: Corticosteroid response rectal gene signature and associated microbial variation in treatment naïve ulcerative colitis
Year: 2019
Source: Scientific Programme
Authors: Yael Haberman
Created: Wednesday, 5 June 2019, 9:01 PM
Oral Presentation: OP20: Mucosal micoRNA profiles predict response to autologous stem-cell transplantation in Crohn’s Disease
Year: 2019
Source: Scientific Programme
Authors: Amy Lewis
Created: Wednesday, 5 June 2019, 9:01 PM